Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Atmos Energy Corporation (ATO) vs CVS Health Corp (CVS) Price & Performance

Atmos Energy CorporationTrade
CVS Health CorpTrade

Price performance (Past 24H)

Key statistics

Atmos Energy Corporation vs CVS Health Corp — how do they compare? Atmos Energy Corporation trades at $168.76 (market cap $28.38B), while CVS Health Corp trades at $93.54 (market cap $122.36B). The key difference: CVS Health Corp is far larger — about 4.3× Atmos Energy Corporation's market cap, and CVS Health Corp pays the higher dividend (2.78%). Which is the better fit depends on your goals.

ATOCVS
Market Cap
$28.38B$122.36B
Sector
UtilitiesHealth
52-Week High
$192.25$110.60
52-Week Low
$162.44$64.88
Enterprise Value
$38.18B$184.71B
Dividend Yield
2.38%2.78%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Atmos Energy Corporation

Atmos Energy (ATO) trades at $170.19, down 1.04% today, with a bearish technical signal despite recent earnings beats. The company reported Q2 2026 EPS of $1.43, beating expectations by 5.9%, and maintains strong fundamentals with 28.5% net income margin and $4.70B revenue. Recent board appointments and dividend declarations highlight corporate stability, while analyst consensus targets $190.57 with 45% buy ratings.

ATO presents a mixed outlook with solid earnings growth and dividend stability offset by bearish technical indicators and negative cash flow trends. The stock offers value through consistent profitability and infrastructure investments, though investors face risks from high capital expenditures and debt levels that could pressure future returns.

CVS Health Corp

CVS Health trades at $95.70, down 0.54% on the day, with a bearish technical signal and key support at $95. The company reported strong Q2 2026 earnings, beating estimates with EPS of $2.58 versus $1.87 expected, and raised its full-year guidance. Revenue growth remains robust, reaching $402.07 billion in 2025, though net income margin compressed to 1.18%. Analyst sentiment is overwhelmingly positive with a consensus price target of $115.00.

The outlook for CVS is cautiously optimistic, driven by operational improvements in its Aetna segment and raised cash flow guidance. Investment opportunities include potential upside to the consensus target, but risks involve margin pressures, regulatory changes impacting pharmacy benefits in 2027, and high debt levels. The stock's current valuation at a P/E of 25.25 may limit near-term gains if earnings growth slows.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Atmos Energy Corporation

Atmos Energy is the largest publicly traded, fully regulated, pure-play natural gas utility in the United States, serving more than 3 million customers in Texas, Colorado, Kansas, Kentucky, Louisiana, Mississippi, Tennessee, and Virginia. About two thirds of its earnings come from Texas, where it distributes natural gas in northern Texas and owns an intrastate gas pipeline spanning several key shale gas formations and interconnected with five storage facilities.

Read more on ATO

About CVS Health Corp

Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.

Read more on CVS